4//SEC Filing
Malley Thomas 4
Accession 0001415889-25-015796
CIK 0001730430other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:02 PM ET
Size
12.9 KB
Accession
0001415889-25-015796
Insider Transaction Report
Form 4
Malley Thomas
Director
Transactions
- Award
Share Option
2025-06-03+16,798→ 16,798 totalExercise: $29.11Exp: 2035-06-02→ Class A Ordinary Shares (16,798 underlying) - Award
Restricted Share Units
2025-06-03+2,799→ 2,799 total→ Class A Ordinary Shares (2,799 underlying) - Exercise/Conversion
Class A Ordinary Shares
2025-06-05+3,173→ 12,546 total - Exercise/Conversion
Restricted Share Units
2025-06-05−3,173→ 0 total→ Class A Ordinary Shares (3,173 underlying)
Holdings
- 71,967(indirect: See footnote)
Class A Ordinary Shares
Footnotes (5)
- [F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
- [F2]Mr. Malley is the president of Mossrock Capital, LLC (Mossrock) and may be deemed to beneficially own the shares owned by Mossrock.
- [F3]The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025.
- [F4]The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025.
- [F5]The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs.
Documents
Issuer
Kiniksa Pharmaceuticals International, plc
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001403322
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:02 PM ET
- Size
- 12.9 KB